PTC Therapeutics, Inc.

PTCTNASDAQUSD
70.97 USD
0.33 (0.47%)AT CLOSE (11:59 AM EDT)
70.97
0.01 (0.01%)
POST MARKET (AS OF 04:19 PM EDT)
Post Market
AS OF 04:19 PM EDT
70.97
0.01 (0.01%)
🔴Market: CLOSED
Open?$70.78
High?$72.97
Low?$69.92
Prev. Close?$70.64
Volume?937.1K
Avg. Volume?1.4M
VWAP?$71.42
Rel. Volume?0.66x
Bid / Ask
Bid?$28.18 × 200
Ask?$80.00 × 200
Spread?$51.82
Midpoint?$54.09
Valuation & Ratios
Market Cap?5.9B
Shares Out?82.9M
Float?75.5M
Float %?94.1%
P/E Ratio?N/A
P/B Ratio?-32.62
EPS?-$2.25
Dividend?0.00%
Ex-Dividend?N/A

Shares of PTC Therapeutics, Inc. (PTCT) are trading at $70.97. PTCT shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (103.5%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, PTCT is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Employees
991
Market Cap
5.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2013-06-20
Address
500 WARREN CORPORATE CENTER DRIVE
WARREN, NJ 07059
Phone: (908) 222-7000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
5
Momentum?
35
Short Sent.?
60
Piotroski F-Score?2/9Weak
Altman Z-Score?0.49Distress
Confidence?65%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.56%High
Short Interest?10.2M
Days to Cover?6.0
Free Float75.5M
Avg Daily Volume1.7M
Settlement Date2026-05-15
Financial Health
Current Ratio?2.44Strong
Quick Ratio?2.36Strong
Cash Ratio?0.90Adequate
Debt/Equity?-1.62Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
S&P
97
-32.62CHEAP
P/S?
Peers
100
S&P
17
7.12HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-277.0CHEAP
EV/Sales?
Peers
100
S&P
24
6.46HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
97
103.5%STRONG
ROA?
S&P
3
-6.5%WEAK
Cash Flow & Enterprise
FCF?$-226282000
Enterprise Value?$5.3B
Fundamentals ratios updated end of day